Cartesian Therapeutics (RNAC) Prepaid Assets (2015 - 2026)

Cartesian Therapeutics (RNAC) has 12 years of Prepaid Assets data on file, last reported at $3.1 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $3.1 million, up 7.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 7.39% YoY), and the FY2025 annual result was $3.0 million, down 3.88% from the prior year.
• Prepaid Assets rose to $3.1 million in Q1 2026 per RNAC's latest filing, from $3.0 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $6.5 million in Q2 2022 and troughed at $2.0 million in Q2 2024.
• A 5-year average of $3.9 million and a median of $3.5 million in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2024 and 2025: Prepaid Assets plunged 52.0% in 2024, then soared 32.93% in 2025.
• A 5-year view of Prepaid Assets shows it stood at $3.8 million in 2022, then jumped by 31.47% to $5.0 million in 2023, then tumbled by 36.7% to $3.1 million in 2024, then declined by 3.88% to $3.0 million in 2025, then advanced by 3.81% to $3.1 million in 2026.
• Business Quant data shows RNAC's Prepaid Assets at $3.1 million in Q1 2026, $3.0 million in Q4 2025, and $3.2 million in Q3 2025.